Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript
Appointed director

NEUROCRINE BIOSCIENCES INC (NBIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 8-K Other Events  Interactive Data
10/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Neurocrine Biosciences Announces Phase 3 Pediatric Study Results of Crinecerfont in Children and Adolescents for the Treatment of Congenital Adrenal Hyperplasia Met Primary and Key Secondary Endpoints"
10/04/2023 4 Boyer David W. (Chief Corp. Affairs Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 1,437 shares @ $112.68, valued at $161.9k
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/23/2023 4 ROBERTS EIRY (Chief Medical Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 3,198 shares @ $107.3758, valued at $343.4k
08/23/2023 4 Onyia Jude (Chief Scientific Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 3,198 shares @ $107.3696, valued at $343.4k
08/23/2023 4 Lippoldt Darin (Chief Legal Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 2,132 shares @ $107.388, valued at $229k
08/23/2023 4 GORMAN KEVIN CHARLES (CEO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 9,328 shares @ $107.3988, valued at $1M
08/23/2023 4 Gano Kyle (Chief Business Development Off) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 2,132 shares @ $107.4075, valued at $229k
08/23/2023 4 Delaet Ingrid (Chief Regulatory Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 1,404 shares @ $107.4219, valued at $150.8k
08/23/2023 4 Cooke Julie (Chief Human Resources Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 2,132 shares @ $107.4065, valued at $229k
08/23/2023 4 Boyer David W. (Chief Corp. Affairs Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 1,600 shares @ $107.4138, valued at $171.9k
08/23/2023 4 BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 1,600 shares @ $107.3975, valued at $171.8k
08/23/2023 4 ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Sold 2,132 shares @ $107.3914, valued at $229k
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/22/2023 144 Form 144 - Report of proposed sale of securities:
08/01/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
07/13/2023 4 POON CHRISTINE A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Granted 16,375 options to buy @ $98.19, valued at $1.6M
07/13/2023 3 POON CHRISTINE A (Director) has filed a Form 3 on NEUROCRINE BIOSCIENCES INC
07/13/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/11/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BYLAW AMENDMENT"
05/19/2023 4 SHERWIN STEPHEN A (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Granted 4,199 restricted stock units @ $0
05/19/2023 4 Sharp Shalini (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Granted 4,290 options to buy @ $95.27, valued at $408.7k
Granted 2,100 restricted stock units @ $0
05/19/2023 4 RASTETTER WILLIAM H (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC
Txns: Granted 8,579 options to buy @ $95.27, valued at $817.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy